C0541315||Everolimus
C0087111||Treatment
C0018915||Pseudomyogenic Hemangioendothelioma
C0018915||Pseudomyogenic hemangioendothelioma
C0018915||Pseudomyogenic hemangioendothelioma
C0282607||vascular neoplasm
C0225317||soft tissue
C0018915||Pseudomyogenic hemangioendothelioma
C0013227||medications
C0018915||Pseudomyogenic hemangioendothelioma
C0521982||responded to treatment
C0541315||everolimus
C2746052||mammalian target of rapamycin inhibitor
C0021044||Immunohistochemistry
C1307407||mammalian target of rapamycin
C1171362||expressed
C0018915||Pseudomyogenic hemangioendothelioma
C0677862||biopsy specimens
C0018915||Pseudomyogenic hemangioendothelioma
C0475440||tumor size
C0087111||treatment